Skip to main content
. 2019 Jul 30;20:169. doi: 10.1186/s12931-019-1134-7

Fig. 2.

Fig. 2

Ratio of the annual rate of clinically significant exacerbations. Mepolizumab 100 mg SC versus placebo. BMI body mass index, CI confidence interval, SC subcutaneous